Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 76 of 76 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/12/22
End: 03/31/26
Due: 03/31/27
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Extension Study to Evaluate How Safe and Tolerable NBI-921352 is as an Adjunctive Therapy for Participants With SCN8A-DEE | NCT05226780 | Neurocrine Biosciences | user2@example.com | None | 2022-07-12 | 2026-03-31 | 2027-03-31 | - | - | 2025-07-14 |